Canada: Health Canada Provides Update on Re-Evaluations of Three Neonicotinoids

Health Canada has provided an update on the re-evaluation of three neonicotinoids (imidacloprid, clothianidin, and thiamethoxam) and proposed timelines for the final re-evaluation decisions. Final reviews related to pollinators for the three neonicotinoids were completed in April 2019. Certain uses are canceled and others are amended with mitigation measures required to be in place by April 2021. The final comprehensive re-evaluation decision for imidacloprid is scheduled to be published in Fall 2020. Final comprehensive re-evaluation decisions for clothianidin and thiamethoxam will follow the release of the aquatic risk decisions. Currently, there are no indications for a review of maximum reside limits (MRL) for these chemistries. 

Canada: Health Canada Provides Update on Re-Evaluations of Three Neonicotinoids